Search
Now showing items 21-40 of 647
Interactive mapping: overlaying local and national data
(2010-03)
The Center for Applied Research and Environmental Systems (CARES) at the University of Missouri-Columbia has a long history of integrating Internet accessibility with emerging technologies to assist underserved, under-resourced, and special needs...
Plants are just very slow animals
(2010-03)
Most of us regard plants as quite different from animals, and many of us think of them as furniture. But plants actually share a very large number of biological functions with the animal kingdom, including mechanisms for ...
Financial Downturn and Impact on Biosciences Development
(University of Missouri (System), 2010-03)
Thomas Melzer spoke about the impact that the recent financial downturn has had on venture capital investment, specifically addressing bioscience investments.
Early Cancer Screening with Pteridines as Biomarkers
(2010-03)
. The detailed experimental conditions will be presented at the life science summit. After analysis of over 60 urine samples from cancer patients, we also discovered that two chemical components exist only in the urine of cancer patients but are not present...
The Institute for Advancing Medical Innovation: stepping into the future of drug discovery, delivery and biomedical engineering
(University of Missouri (System), 2010-03)
Inspired by the opportunity to grow educational and entrepreneurial capacity, the Institute for Advancing Medical Innovation (IAMI) was established upon the belief that: ideas are translated to innovation to improve health. ...
Innovation, Inspiration, and Insulation: Practical Legal Measures to Protect Technology
(2010-03)
The demand for new technologies is driving innovation worldwide, particularly in the fields of life sciences and biotechnology. Intellectual Property is the life blood of many life sciences and biotechnology companies. Protecting the IP...
Synthetic genomics in an era of personalized medicine
(University of Missouri (System), 2010-03)
Synthetic genomics is a new field that engages in the design and assembly of genes and chromosomes from chemically synthesized oligonucleotides to create cells with properties unobtainable by conventional molecular biology ...
Biomaterials for Tissue Repair and Regeneration at Missouri S&T
(2010-03)
Biomaterials are critically important to future developments in the life sciences. They provide a backbone for biomedical research in academia and industry, and are a key component of reconstructive medical and dental research as well as patient...
The Vision Research Center of Kansas City
(2010-03)
The Vision Research Center was founded as and is a well established collaboration of several of UMKC schools and Kansas City Medical Centers and thus offers an unprecedented interdisciplinary synergy with a unified goal: ...
Experiences in Patenting, Licensing and Commercialization of Radiopharmaceuticals
(2010-02)
three different approaches in developing corporate agreements that were successful in translating MU life sciences research into radiopharmaceuticals that are for use as diagnostic and therapeutic applications in human patients....
In silico Compound Screening for Drug Discovery in the “Cloud”
(2010-03)
The need to identify new small molecules and novel binding partners for known bioactive sites remains a constant in drug development. We are aiding VaSSA Informatics in creating informatics methods used to identify ...
The “Male Pill”: The Learning Curve from Basic Science to the Drug Development Pipeline and the Strength of Interdisciplinary Collaboration
(2010-03)
contraceptive methods remain the most widely used. There are many couples where the female cannot use existing methods. For the male, effective contraceptive methods are limited to condoms and vasectomy. NIH, WHO, and the National Academy of Science Institute...
Genetically-modified animals: powerful tools for biomedical research
(2010)
The University of Missouri houses three National Institutes of Health (NIH), National Center for Research Resources (NCRR) animal resource centers. These animal resource centers are: (1) the Mutant Mouse Regional Resource Center (MMRRC); (2) the Rat...
Patent litigation issues
(2010-03)
Joe Mahoney addressed issues of patent law and patent infringement, citing several examples from the pharmaceutical industry.
Comparative Ophthalmology - scientific discovery and innovation create synergies for veterinary and human medicine
(2010-03)
of vision loss. Many technological innovations have been made which give doctors and scientists unprecedented insights to mechanisms of the eye and effects of treatment in animal models and humans. This presentation will briefly touch on recent...
Integrating academic research, clinical research and private practice: a unique opportunity for translational medicine
(2010-03)
researched to develop new therapy approaches urgently needed by physicians in the US and worldwide, transferring basic science findings seamlessly into practical use with patients....
Navigating the FDA and understanding medical device preemption
(2010-03)
FDA's Center for Devices and Radiological Health (CDRH) is responsible for regulating firms who manufacture, repackage, relabel, and/or import medical devices sold in the United States. In addition, CDRH regulates ...
Navigating the two-way street of comparative oncology
(2010)
Companion animals offer a unique model for study of spontaneously occurring cancer for many reasons. Our pets share our environment, thus may have similar exposure to environmental carcinogens. The technology for diagnosis ...
Training Tomorrows Entrepreneurs Today
(2010-02)
and innovation. Additionally, the program is dedicated to the development and facilitation of interdisciplinary collaboration between faculty and students to increase innovation at the University of Missouri. With the financial support of the Department...
Clinical Translation of Nanopharmaceuticals for Cancer Therapy [abstract]
(2010-02)
and biocompatible gold nanoparticles can be used as new generation of building blocks in the design and development of targeted cancer therapeutic agents. This presentation will discuss latest findings from our laboratory on the development of glyco protein...